NO20042440L - Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib - Google Patents

Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Info

Publication number
NO20042440L
NO20042440L NO20042440A NO20042440A NO20042440L NO 20042440 L NO20042440 L NO 20042440L NO 20042440 A NO20042440 A NO 20042440A NO 20042440 A NO20042440 A NO 20042440A NO 20042440 L NO20042440 L NO 20042440L
Authority
NO
Norway
Prior art keywords
parecoxib
dosage form
oral dosage
sulfonamide
prodrug
Prior art date
Application number
NO20042440A
Other languages
English (en)
Norwegian (no)
Inventor
Aziz Karim
Sandeep Nema
Gary D Ewing
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20042440L publication Critical patent/NO20042440L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20042440A 2001-11-13 2004-06-11 Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib NO20042440L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35059601P 2001-11-13 2001-11-13
PCT/US2002/036253 WO2003041705A1 (en) 2001-11-13 2002-11-12 Oral dosage form of a sulfonamide prodrug such as parecoxib

Publications (1)

Publication Number Publication Date
NO20042440L true NO20042440L (no) 2004-08-09

Family

ID=23377399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042440A NO20042440L (no) 2001-11-13 2004-06-11 Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Country Status (20)

Country Link
US (1) US20030100595A1 (de)
EP (1) EP1446118B1 (de)
JP (1) JP2005509002A (de)
KR (1) KR20050044459A (de)
CN (1) CN1615135A (de)
AR (1) AR037356A1 (de)
AT (1) ATE383156T1 (de)
BR (1) BR0214081A (de)
CA (1) CA2466504A1 (de)
CO (1) CO5580744A2 (de)
DE (1) DE60224558T2 (de)
ES (1) ES2297032T3 (de)
IL (1) IL161991A0 (de)
MX (1) MXPA04004476A (de)
NO (1) NO20042440L (de)
PL (1) PL369962A1 (de)
RU (1) RU2004114552A (de)
TW (1) TW200300680A (de)
WO (1) WO2003041705A1 (de)
ZA (1) ZA200403328B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785640B2 (en) 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
WO2007038421A2 (en) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Berry preparations and extracts
EP1940382A2 (de) * 2005-10-07 2008-07-09 Aditech Pharma AB Kombinationstherapie mit fumarsäureestern zur behandlung von autoimmunkrankheiten und/oder entzündlichen erkrankungen
CA2661274A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
KR20100099113A (ko) * 2007-10-12 2010-09-10 아스트라제네카 아베 만니톨 및/또는 미세결정질 셀룰로스를 포함하는 지보텐탄 조성물
EP2564839B1 (de) 2009-01-09 2016-05-11 Forward Pharma A/S Pharmazeutische Formulierung mit einem oder mehreren Fumarsäureestern in einer Erosionsmatrix
JP6102120B2 (ja) * 2012-08-16 2017-03-29 ニプロ株式会社 医薬製剤およびその製造方法
CN104771370B (zh) * 2014-01-14 2020-07-24 南京圣和药业股份有限公司 帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) * 2015-06-11 2016-06-29 成都克莱蒙医药科技有限公司 一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) * 2016-06-21 2018-11-02 马鞍山丰原制药有限公司 一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) * 2020-11-24 2021-02-26 苏州璞正医药有限公司 一种帕瑞昔布衍生物及其制备方法和应用
WO2024208166A1 (zh) * 2023-04-04 2024-10-10 上海汇伦医药股份有限公司 西维来司他用于镇痛的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0729748B1 (de) * 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Verfahren zur herstellung stabiler arzneimittel
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GEP20032998B (en) * 1996-04-12 2003-06-25 Searle & Co Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
WO2001028548A1 (en) * 1999-10-19 2001-04-26 Texas Heart Institute Treatment of heart disease with cox-2 inhibitors
HRP20010582A2 (en) * 1999-12-08 2002-08-31 Pharmacia Corp Valdecoxib compositions
KR100717549B1 (ko) * 1999-12-22 2007-05-11 파마시아 코포레이션 시클로옥시게나제-2 억제제의 이중-방출 조성물
US6586474B2 (en) * 2000-03-24 2003-07-01 Pharmacia Corporation Amidino compounds useful as nitric oxide synthase inhibitors
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
CA2415697A1 (en) * 2000-07-13 2002-01-24 James C. Forbes Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
PE20021017A1 (es) * 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible

Also Published As

Publication number Publication date
ATE383156T1 (de) 2008-01-15
US20030100595A1 (en) 2003-05-29
ES2297032T3 (es) 2008-05-01
PL369962A1 (en) 2005-05-02
WO2003041705A1 (en) 2003-05-22
CA2466504A1 (en) 2003-05-22
DE60224558T2 (de) 2009-01-22
RU2004114552A (ru) 2005-02-20
KR20050044459A (ko) 2005-05-12
JP2005509002A (ja) 2005-04-07
IL161991A0 (en) 2005-11-20
EP1446118A1 (de) 2004-08-18
ZA200403328B (en) 2005-04-13
EP1446118B1 (de) 2008-01-09
DE60224558D1 (de) 2008-02-21
TW200300680A (en) 2003-06-16
BR0214081A (pt) 2004-09-28
CN1615135A (zh) 2005-05-11
MXPA04004476A (es) 2004-08-11
CO5580744A2 (es) 2005-11-30
AR037356A1 (es) 2004-11-03

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
NO20033343L (no) Farmasöytiske doseringsformer av epothiloner for oral administrasjon
ITMI20021876A1 (it) Procedimento migliorato per realizzare un rotore di un
DE60307379D1 (de) Ausfallsichere filmgekühlte Wand
DK1545475T3 (da) Enterisk sammensætning til fremstillingen af blød kapselvæg
ATE380544T1 (de) Umhüllte feste darreichungsform
EE05581B1 (et) Aripiprasooli ravimlahus peroraalseks manustamiseks
SI1379220T1 (sl) Inhalacijske kapsule
NO20052474D0 (no) Amort form av esomeprazolsalter
IS7177A (is) Valdekoxíb samsetningar sem leysast upp í munni
IL161991A0 (en) Oral dosage form of a sulfonamide prodrug such as parecoxib
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
NO20034556D0 (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
FI20000780A0 (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20055612D0 (no) Anti-inflammatoriske fosfonatforbindelser
IS7219A (is) Lyfjablanda sem inniheldur (R) -bíkalútamíð
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
DK1474114T3 (da) Oral doseringsform til reguleret frigivelse af et lægemiddel
DK1515959T3 (da) Farmaceutiske salte af reboxetin
NO20035547D0 (no) Fremgangsmåte for fremstilling av paroksetin HCl som begrenser dannelse avrosafargede forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application